Verdegaal, Els http://orcid.org/0000-0002-4449-8707
van der Kooij, Monique K http://orcid.org/0000-0002-9764-5467
Visser, Marten
van der Minne, Caroline
de Bruin, Linda
Meij, Pauline
Terwisscha van Scheltinga, Anton
Welters, Marij J
Santegoets, Saskia
de Miranda, Noel http://orcid.org/0000-0001-6122-1024
Roozen, Inge
Liefers, Gerrit Jan
Kapiteijn, Ellen
van der Burg, Sjoerd H http://orcid.org/0000-0002-6556-0354
Clinical trials referenced in this document:
Documents that mention this clinical trial
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study
https://doi.org/10.1136/jitc-2019-000166
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial (Pre-results)
https://doi.org/10.1136/bmjopen-2020-044036
Funding for this research was provided by:
Duth Cancer Society (KWF grants 2012-5544 and 2017-10815)